REQUEST A DEMO
Total
USD $0.00
Search more companies

Hans Bio Med Corporation (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Hans Bio Med Corporation Profile Updated: March 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Hans Biomed Corporation. The Company's principal activity is providing biotechnology products. It provides three categories of products: products for skin implant, products for bone implant and silicone products. The products for skin implant include SureDerm, which is acellular human dermis used for the repair or replacement of damaged soft tissue; GPS, which is glycerol preserved skin used as wound dressing, and Sheba, which is micronized injectable human tissue for the correction of wrinkles and dents on the face. The products for bone implant include SureFuse, which is mixture of demineralized bone matrix (DBM) used for forming normal healthy bone by stimulation of mesenchymal cell proliferation; ExFuse, which is DBM to which cancellous bone chip is added, and SureOss, which is made of freeze dried cortical bone and helps bone regeneration. The silicone products include treatments for scars, and silicone materials for facial implant, nasal implant, breast implant and others.

Headquarters
Room 807 Sk Bldg, 16-4 Seongsu 1Ga 2-Dong, Seongdong-Gu
Seoul; Seoul; Postal Code: 133-822

Contact Details: Purchase the Hans Bio Med Corporation report to view the information.

Website: http://www.hansbiomed.com

Basic Information
Total Employees:
Purchase the Hans Bio Med Corporation report to view the information.
Outstanding Shares:
Purchase the Hans Bio Med Corporation report to view the information.
Registered Capital:
Purchase the Hans Bio Med Corporation report to view the information.
Financial Auditors:
Purchase the Hans Bio Med Corporation report to view the information.
Incorporation Date:
September 15, 1999
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
21.11%
Purchase this report to view the information.
0.68%
Purchase this report to view the information.
0.53%
Purchase this report to view the information.
0.47%
Purchase this report to view the information.
0.32%
Subsidiaries
Hansbiomed Europe Ltd (United Kingdom)
Hansbiomed Mexico (Mexico)
Hansbiomed S.A.S (Colombia)
Company Performance
Financial values in the chart are available after Hans Bio Med Corporation report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
4.8%
Total operating revenue
6.11%
Operating profit (EBIT)
-202.63%
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
-7.08%
Total equity
5.26%
Operating Profit Margin (ROS)
-5.6%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-35.45%
Quick Ratio
-0.02%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?